Revenue (Tables)

6 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Abstract]

Revenue by product for the periods indicated were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2026		2025		2026		2025
CHEMOSAT	$	1,972	$	1,656	$	3,719	$	3,417
HEPZATO KIT	27,161		22,500		50,408		40,523
Total revenue	$	29,133	$	24,156	$	54,127	$	43,940

Schedule of Revenue and Accounts Receivable Concentrations

The Company’s total percentage of revenue and accounts receivable balances were comprised of the following concentrations from its largest customers, based on whose revenue and/or accounts receivable concentration is greater than 10% of the Company’s total revenue or total accounts receivable in the periods disclosed below:


For the six months ended and as of June 30, 2026	% of Revenue		% of Accounts Receivable
Customer 1	18.8	%	19.0	%
Customer 2	10.4	%	13.6	%
Customer 3	8.4	%	13.0	%


For the six months ended and as of June 30, 2025	% of Revenue		% of Accounts Receivable
Customer 1	13.1	%	11.8	%
Customer 2	12.3	%	14.2	%
Customer 3	11.0	%	5.9	%